ShEEP Request for Enabling 3D Nano-Printer Technology
ShEEP Request for Enabling 3D Nano-Printer Technology
批准号:
10179144
负责人:
JASON A WERTHEIM
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-10-01 至 2021-09-30
关键词:
3-Dimensional3D PrintAmyotrophic Lateral SclerosisArizonaAsiaAwardBiologicalBiomedical EngineeringBlood VesselsBlood capillariesBuffaloesCaliberCell Differentiation processCellsCellular biologyCharacteristicsChemicalsCitiesClostridium difficileCollaborationsDevelopmentDevicesEnergy TransferEnsureEnzyme Inhibitor DrugsEquipmentFeesFundingGeometryGlycoproteinsGoalsGrowth FactorHealthcareHealthcare SystemsHeart DiseasesHuman BiologyInkInstitutionKidneyKidney FailureLeadLengthLigandsLightLiver DysfunctionLocationMarylandMedical centerMethodsMicrobiologyMicrofluidic MicrochipsMicrofluidicsMinorMississippiMolecularMyeloma ProteinsNephronsNew YorkNonprofit OrganizationsOligonucleotidesPatternPeptidesPerfusionPharmaceutical PreparationsPolymersPrintingProcessProteinsPulmonary FibrosisReproducibilityResearchResearch PersonnelResolutionRiversScanningSeriesServicesSheepStem Cell DevelopmentStructureSurfaceSystemTechnologyTimeTissue EngineeringTubeUltraviolet RaysUniversitiesVeteransWritingbasebiological systemsdesigndrug discoveryhigh-throughput drug screeningimprovedinnovationinstrumentinstrumentationlithographymillimetermolecular arraynanonanometernanopatternnovelnovel therapeuticsoperationreceptor
中文摘要
项目概要/摘要
所要求的仪器是用于生物应用的先进3D打印系统,其克服了
传统增材制造打印设备的长度尺度限制。仪表
利用直接分子印刷和紫外光能转移两种串联技术,
生物工程设备是均匀的,高度可控的,并具有分辨率和长度尺度,
纳米到微米范围。该仪器设计用于生产可控的分子阵列,
研究受体-配体、蛋白质-蛋白质或酶-抑制剂相互作用,具体应用于:1)
组织工程,2)影响细胞分化和功能的基于细胞的研究,3)药物发现,
4)微生物学.仪器的主要目标是制造新型生物工程装置,
肽、糖蛋白或寡核苷酸的阵列;精确定义的微流体通道;以及
或几何定制的生物功能芯片,以推进上述研究领域,涵盖VA资助的
亚利桑那州南部VA医疗保健系统(SAVAHCS)。此外,3D纳米打印系统
可以由学术分支机构亚利桑那大学的研究人员和其他合作者访问
在整个地区,这将扩大仪器的影响,并加强研究合作,
特别是在附近的两个医疗中心之间,以及整个西南地区。
英文摘要
PROJECT SUMMARY/ABSTRACT
The requested instrumentation is an advanced 3D printing system for biological applications that overcomes
much of the length-scale limitations of traditional additive manufacturing printing devices. The instrumentation
utilizes two tandem technologies of direct molecular printing and ultraviolet light energy transfer to develop
bioengineered devices that are uniform, highly controllable and have resolution and length-scales in the
nanometer to micrometer-range. The instrumentation is designed to produce controllable, molecular arrays to
investigate receptor-ligand, protein-protein, or enzyme-inhibitor interactions with specific applications to: 1)
tissue engineering, 2) cell-based studies that influence cellular differentiation and function, 3) drug discovery and
4) microbiology. The primary goal of the instrumentation is to fabricate novel bioengineered devices that consist
of arrays of peptides, glycoproteins or oligonucleotides; precisely defined microfluidic channels; and chemically
or geometrically tailored biofunctional chips to advance the research domains listed above that cover VA-funded
research at the Southern Arizona VA Health Care System (SAVAHCS). Additionally, the 3D nano-printing system
may be accessed by investigators at the academic affiliate, the University of Arizona, and other collaborators
throughout the region, which will expand the impact of the instrumentation and enhance research collaborations,
specifically between the two nearby medical centers and generally throughout the southwestern region.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Repairing the Kidney Endothelium via Targeted Extracellular Matrix Modifiers
-
批准号:10213014
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2020
-
负责人:JASON A WERTHEIM
-
依托单位:
Repairing the Kidney Endothelium via Targeted Extracellular Matrix Modifiers
-
批准号:10454117
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2020
-
负责人:JASON A WERTHEIM
-
依托单位:
Repairing the Kidney Endothelium via Targeted Extracellular Matrix Modifiers
-
批准号:10205482
-
项目类别:
-
资助金额:$30.7万
-
财政年份:2020
-
负责人:JASON A WERTHEIM
-
依托单位:
Repairing the Kidney Endothelium via Targeted Extracellular Matrix Modifiers
-
批准号:9449094
-
项目类别:
-
资助金额:$31.6万
-
财政年份:2018
-
负责人:JASON A WERTHEIM
-
依托单位:
Extracellular Matrix Induction of Renal Stem and Progenitor Cell Development
-
批准号:10200365
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:JASON A WERTHEIM
-
依托单位:
Optimization and control of hepatocyte activity via biofunctional modification
-
批准号:9246530
-
项目类别:
-
资助金额:$16.17万
-
财政年份:2014
-
负责人:JASON A WERTHEIM
-
依托单位:
Optimization and control of hepatocyte activity via biofunctional modification
-
批准号:8679763
-
项目类别:
-
资助金额:$15.13万
-
财政年份:2014
-
负责人:JASON A WERTHEIM
-
依托单位:
海外基金